Amanote Research
Register
Sign In
BACE2, a Conditional Β-Secretase, Contributes to Alzheimer’s Disease Pathogenesis
JCI insight
- United States
doi 10.1172/jci.insight.123431
Full Text
Open PDF
Abstract
Available in
full text
Categories
Medicine
Date
January 10, 2019
Authors
Zhe Wang
Qin Xu
Fang Cai
Xi Liu
Yili Wu
Weihong Song
Publisher
American Society for Clinical Investigation
Related search
Β-Arrestin 2 Regulates Aβ Generation and Γ-Secretase Activity in Alzheimer’s Disease
Molecular Neurodegeneration
Molecular Neuroscience
Neurology
Molecular Biology
Cellular
Β-Amyloid: The Key Peptide in the Pathogenesis of Alzheimer’s Disease
Frontiers in Pharmacology
Pharmacology
Γ-Secretase Inhibitors and Modulators for Alzheimer’s Disease
Journal of Neurochemistry
Biochemistry
Molecular Neuroscience
Cellular
Microglia Receptors and Their Implications in the Response to Amyloid Β for Alzheimer’s Disease Pathogenesis
Journal of Neuroinflammation
Molecular Neuroscience
Neurology
Immunology
Cellular
Neuroscience
Correction To: Complement in the Pathogenesis of Alzheimer’s Disease
Seminars in Immunopathology
Allergy
Immunology
Metalloproteinase PAPP-A Regulation of IGF-1 Contributes to Polycystic Kidney Disease Pathogenesis
JCI insight
Medicine
Trans-Synaptic Spread of Amyloid-Β in Alzheimer’s Disease: Paths to Β-Amyloidosis
Neural Plasticity
Neurology
Targeting the Β Secretase BACE1 for Alzheimer's Disease Therapy
The Lancet Neurology
Neurology
Cholinergic–serotonergic Imbalance Contributes to Cognitive and Behavioral Symptoms in Alzheimer’s Disease
Neuropsychologia
Cognitive Neuroscience
Behavioral Neuroscience
Experimental
Cognitive Psychology